These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 15690531

  • 1. Antifibrinolytics in orthotopic liver transplantation: current status and controversies.
    Xia VW, Steadman RH.
    Liver Transpl; 2005 Jan; 11(1):10-8. PubMed ID: 15690531
    [Abstract] [Full Text] [Related]

  • 2. Antifibrinolytics in liver transplantation.
    Groenland TH, Porte RJ.
    Int Anesthesiol Clin; 2006 Jan; 44(3):83-97. PubMed ID: 16832208
    [No Abstract] [Full Text] [Related]

  • 3. Lessons from aprotinin: is the routine use and inconsistent dosing of tranexamic acid prudent? Meta-analysis of randomised and large matched observational studies.
    Ngaage DL, Bland JM.
    Eur J Cardiothorac Surg; 2010 Jun; 37(6):1375-83. PubMed ID: 20117944
    [Abstract] [Full Text] [Related]

  • 4. Antifibrinolytics.
    Schmarts.
    Acta Anaesthesiol Belg; 2003 Jun; 54(4):319-22. PubMed ID: 14719353
    [No Abstract] [Full Text] [Related]

  • 5. Are antifibrinolytics helpful in decreasing blood loss and transfusions during spinal fusion surgery in children with cerebral palsy scoliosis?
    Dhawale AA, Shah SA, Sponseller PD, Bastrom T, Neiss G, Yorgova P, Newton PO, Yaszay B, Abel MF, Shufflebarger H, Gabos PG, Dabney KW, Miller F.
    Spine (Phila Pa 1976); 2012 Apr 20; 37(9):E549-55. PubMed ID: 22037532
    [Abstract] [Full Text] [Related]

  • 6. Tranexamic acid and aprotinin in low- and intermediate-risk cardiac surgery: a non-sponsored, double-blind, randomised, placebo-controlled trial.
    Later AF, Maas JJ, Engbers FH, Versteegh MI, Bruggemans EF, Dion RA, Klautz RJ.
    Eur J Cardiothorac Surg; 2009 Aug 20; 36(2):322-9. PubMed ID: 19250838
    [Abstract] [Full Text] [Related]

  • 7. Natural and synthetic antifibrinolytics: inert, poisonous or therapeutic agents?
    Hardy JF, Bélisle S.
    Can J Anaesth; 1997 Sep 20; 44(9):913-7. PubMed ID: 9305552
    [No Abstract] [Full Text] [Related]

  • 8. Synthetic antifibrinolytics are not associated with an increased incidence of baffle fenestration closure after the modified Fontan procedure.
    Gruber EM, Shukla AC, Reid RW, Hickey PR, Hansen DD.
    J Cardiothorac Vasc Anesth; 2000 Jun 20; 14(3):257-9. PubMed ID: 10890476
    [Abstract] [Full Text] [Related]

  • 9. [Can drugs reduce the need for blood transfusion in the course of surgery?].
    Bach KF, Kjoergaard J, Christensen HR.
    Ugeskr Laeger; 1999 Jan 25; 161(4):457-8. PubMed ID: 9951371
    [No Abstract] [Full Text] [Related]

  • 10. Con: Antifibrinolytics are not safe and effective in patients undergoing liver transplantation.
    Ramsay MA.
    J Cardiothorac Vasc Anesth; 2006 Dec 25; 20(6):891-3. PubMed ID: 17138102
    [No Abstract] [Full Text] [Related]

  • 11. Re-evaluation of the role of antifibrinolytic therapy with lysine analogs during cardiac surgery in the post aprotinin era.
    Koster A, Schirmer U.
    Curr Opin Anaesthesiol; 2011 Feb 25; 24(1):92-7. PubMed ID: 20881484
    [Abstract] [Full Text] [Related]

  • 12. Perioperative renal outcome in cardiac surgical patients with preoperative renal dysfunction: aprotinin versus epsilon aminocaproic acid.
    Maslow AD, Chaudrey A, Bert A, Schwartz C, Singh A.
    J Cardiothorac Vasc Anesth; 2008 Feb 25; 22(1):6-15. PubMed ID: 18249324
    [Abstract] [Full Text] [Related]

  • 13. Pro: Antifibrinolytics are safe and effective in patients undergoing liver transplantation.
    Lerner AB.
    J Cardiothorac Vasc Anesth; 2006 Dec 25; 20(6):888-90. PubMed ID: 17138101
    [No Abstract] [Full Text] [Related]

  • 14. Current antifibrinolytic therapy for coronary artery revascularization.
    Trudell J, McMurdy N.
    AANA J; 2008 Apr 25; 76(2):121-4. PubMed ID: 18478817
    [Abstract] [Full Text] [Related]

  • 15. Aprotinin increases mortality as compared with tranexamic acid in cardiac surgery: a meta-analysis of randomized head-to-head trials.
    Takagi H, Manabe H, Kawai N, Goto SN, Umemoto T.
    Interact Cardiovasc Thorac Surg; 2009 Jul 25; 9(1):98-101. PubMed ID: 19380335
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Intravascular thrombosis and thromboembolism during liver transplantation: antifibrinolytic therapy implicated?
    Ramsay MA, Randall HB, Burton EC.
    Liver Transpl; 2004 Feb 25; 10(2):310-4. PubMed ID: 14762872
    [Abstract] [Full Text] [Related]

  • 20. The prophylactic use of tranexamic acid and aprotinin in orthotopic liver transplantation: a comparative study.
    Dalmau A, Sabaté A, Koo M, Bartolomé C, Rafecas A, Figueras J, Jaurrieta E.
    Liver Transpl; 2004 Feb 25; 10(2):279-84. PubMed ID: 14762867
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.